CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

Four sessions across twodays focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including Novo

Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine

Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety

Cytotrait appoints Dr Ian Jepson as Non-Executive Director

Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologiesFollows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform and establish trait enhancem

Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the expansion of its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, f

Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy

Novai.

Big Picture Bio founded to identify, design and optimise promising cancer combination therapies

New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostI

Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform

Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applicationsInvestment led by The FSE Group alongside existi

EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial

Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people

Eppendorf launches new refrigerated Centrifuge 5811 R

Hamburg, Germany, 8 September, 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the launch of the Centrifuge 5811

OutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation

Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, NomalyFunding provided jointly by Innovate UK and Empirical Ventures through Innovate UK Growth Catalyst – Investor Partn

Bio-Rad expands Foresight Pro Prepacked Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing

Extended Range of Process-Scale Columns Prepacked with CEX, AEX, CEX-HIC, and AEX-HIC Chromatography Resins Provides an Effective Solution for Purification of Biomolecules in Downstream Processing

Carterra Enables Anthropic's Autonomous AI Protein Design Study via its HT-SPR Binding Platforms

Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today highlighted the role of Carterra HT-SPR in one of the largest published wet-lab validations of AI-designed proteins to date.

FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation

Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumor-conditional cytokine delivery FJBio engineered dual-specificity Fabs to meet model-defined affinity window through an end-to-end campaign across Porto and

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financingSupports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design across broader range of chest dise

Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of drug-safety across preclinical and clinical settings Early access programme now open for drug developers to shape future platform capabilities and applicationsNew bran

SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing

·       CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer

Calla Lily Clinical Care selected to join Wellcome Leap’s $50M Focused Antibiotics Programme

Callavid intravaginal drug delivery platform selected to advance targeted UTI treatment as part of new programme addressing antibiotic-driven antimicrobial resistance

Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development

•        Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows•        Researchers invited to gain early access to platform and support ongoing product development

DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction

FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies

Qureight closes $20 million Series B financing

Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further accelerate clinica

Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market

New research on AI-driven biologics discovery identifies Carterra's high-throughput SPR platforms as central to the Lab-in-the-Loop (LitL) workflow reshaping drug discovery, with Twist Bioscience and Adaptyv Bio pointing to surging demand for Carterra technology

SynGenSys makes key appointments to strengthen senior commercial and scientific teams

· Heads of Commercial, CHO Expression Technologies, Cell and Gene Therapy Expression Technologies, and Bioinformatics and Data Science appointed to support commercial scale-up

EpilepsyGTx appoints Dr Teresa Nunes as Chief Medical Officer

Appointment of senior clinical leader will support progression of lead candidate EPY201 through the clinic 

FairJourney Bio announces scientific program and leadership for The Antibody Series 2026

Annual event brings together international experts in antibody discovery and development, taking place September 16–18, 2026, in Évora, Portugal